CURHAN GREGORY S 4
4 · Serina Therapeutics, Inc. · Filed Aug 20, 2024
Insider Transaction Report
Form 4
CURHAN GREGORY S
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2024-08-15+250,000→ 250,000 totalExercise: $6.66Exp: 2024-08-15→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The stock options vest in substantially equal monthly installments beginning on September 15, 2024 such that the stock options shall be fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.